Abstract
Summary
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market is projected to reach US$ 64 million by 2030 from an estimated US$ 48 million in 2024, at a CAGR of 5.2% during 2024 and 2030.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Urokinase.
The Urokinase market size, estimations, and forecasts are provided in terms of sales volume (BIU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urokinase market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Segment by Type
Urokinase Powder
Urokinase Solution
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urokinase in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Urokinase market is projected to reach US$ 64 million by 2030 from an estimated US$ 48 million in 2024, at a CAGR of 5.2% during 2024 and 2030.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Urokinase.
The Urokinase market size, estimations, and forecasts are provided in terms of sales volume (BIU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urokinase market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Segment by Type
Urokinase Powder
Urokinase Solution
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urokinase in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Urokinase Product Introduction
1.2 Market by Type
1.2.1 Global Urokinase Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Market by Application
1.3.1 Global Urokinase Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Urokinase Market Size Estimates and Forecasts
2.1.1 Global Urokinase Revenue 2019-2030
2.1.2 Global Urokinase Sales 2019-2030
2.2 Urokinase Market Size by Region: 2023 Versus 2030
2.3 Urokinase Sales by Region (2019-2030)
2.3.1 Global Urokinase Sales by Region: 2019-2024
2.3.2 Global Urokinase Sales Forecast by Region (2025-2030)
2.3.3 Global Urokinase Sales Market Share by Region (2019-2030)
2.4 Urokinase Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Urokinase Revenue by Region: 2019-2024
2.4.2 Global Urokinase Revenue Forecast by Region (2025-2030)
2.4.3 Global Urokinase Revenue Market Share by Region (2019-2030)
3 Global Urokinase by Manufacturers
3.1 Global Top Urokinase Manufacturers by Sales
3.1.1 Global Urokinase Sales by Manufacturer (2019-2024)
3.1.2 Global Urokinase Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Urokinase Manufacturers by Revenue
3.2.1 Global Urokinase Revenue by Manufacturer (2019-2024)
3.2.2 Global Urokinase Revenue Share by Manufacturer (2019-2024)
3.3 Global Urokinase Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Urokinase Manufacturers Covered: Ranking by Revenue
3.4.2 Global Urokinase Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Urokinase Manufacturing Base Distribution, Product Type
3.5.1 Urokinase Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Urokinase Product Type
3.5.3 Date of International Manufacturers Enter into Urokinase Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Syner-Med
4.1.1 Syner-Med Company Information
4.1.2 Syner-Med Description, Business Overview
4.1.3 Syner-Med Urokinase Products Offered
4.1.4 Syner-Med Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Syner-Med Urokinase Sales by Product in 2023
4.1.6 Syner-Med Urokinase Sales by Application in 2023
4.1.7 Syner-Med Urokinase Sales by Geographic Area in 2023
4.1.8 Syner-Med Recent Developments
4.2 Wanhua Biochem
4.2.1 Wanhua Biochem Company Information
4.2.2 Wanhua Biochem Description, Business Overview
4.2.3 Wanhua Biochem Urokinase Products Offered
4.2.4 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Wanhua Biochem Urokinase Sales by Product in 2023
4.2.6 Wanhua Biochem Urokinase Sales by Application in 2023
4.2.7 Wanhua Biochem Urokinase Sales by Geographic Area in 2023
4.2.8 Wanhua Biochem Recent Developments
4.3 Jiangxi Haoran Bio-Pharma
4.3.1 Jiangxi Haoran Bio-Pharma Company Information
4.3.2 Jiangxi Haoran Bio-Pharma Description, Business Overview
4.3.3 Jiangxi Haoran Bio-Pharma Urokinase Products Offered
4.3.4 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Jiangxi Haoran Bio-Pharma Urokinase Sales by Product in 2023
4.3.6 Jiangxi Haoran Bio-Pharma Urokinase Sales by Application in 2023
4.3.7 Jiangxi Haoran Bio-Pharma Urokinase Sales by Geographic Area in 2023
4.3.8 Jiangxi Haoran Bio-Pharma Recent Developments
4.4 Jiangsu Aidea Pharmaceutical
4.4.1 Jiangsu Aidea Pharmaceutical Company Information
4.4.2 Jiangsu Aidea Pharmaceutical Description, Business Overview
4.4.3 Jiangsu Aidea Pharmaceutical Urokinase Products Offered
4.4.4 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Jiangsu Aidea Pharmaceutical Urokinase Sales by Product in 2023
4.4.6 Jiangsu Aidea Pharmaceutical Urokinase Sales by Application in 2023
4.4.7 Jiangsu Aidea Pharmaceutical Urokinase Sales by Geographic Area in 2023
4.4.8 Jiangsu Aidea Pharmaceutical Recent Developments
4.5 Techpool
4.5.1 Techpool Company Information
4.5.2 Techpool Description, Business Overview
4.5.3 Techpool Urokinase Products Offered
4.5.4 Techpool Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Techpool Urokinase Sales by Product in 2023
4.5.6 Techpool Urokinase Sales by Application in 2023
4.5.7 Techpool Urokinase Sales by Geographic Area in 2023
4.5.8 Techpool Recent Developments
4.6 Microbic Biosystems
4.6.1 Microbic Biosystems Company Information
4.6.2 Microbic Biosystems Description, Business Overview
4.6.3 Microbic Biosystems Urokinase Products Offered
4.6.4 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Microbic Biosystems Urokinase Sales by Product in 2023
4.6.6 Microbic Biosystems Urokinase Sales by Application in 2023
4.6.7 Microbic Biosystems Urokinase Sales by Geographic Area in 2023
4.6.8 Microbic Biosystems Recent Development
4.7 LIVZON
4.7.1 LIVZON Company Information
4.7.2 LIVZON Description, Business Overview
4.7.3 LIVZON Urokinase Products Offered
4.7.4 LIVZON Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.7.5 LIVZON Urokinase Sales by Product in 2023
4.7.6 LIVZON Urokinase Sales by Application in 2023
4.7.7 LIVZON Urokinase Sales by Geographic Area in 2023
4.7.8 LIVZON Recent Development
5 Breakdown Data by Type
5.1 Global Urokinase Sales by Type (2019-2030)
5.1.1 Global Urokinase Sales by Type (2019-2024)
5.1.2 Global Urokinase Sales Forecast by Type (2025-2030)
5.1.3 Global Urokinase Sales Market Share by Type (2019-2030)
5.2 Global Urokinase Revenue Forecast by Type (2019-2030)
5.2.1 Global Urokinase Revenue by Type (2019-2024)
5.2.2 Global Urokinase Revenue Forecast by Type (2025-2030)
5.2.3 Global Urokinase Revenue Market Share by Type (2019-2030)
5.3 Urokinase Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Urokinase Sales by Application (2019-2030)
6.1.1 Global Urokinase Sales by Application (2019-2024)
6.1.2 Global Urokinase Sales Forecast by Application (2025-2030)
6.1.3 Global Urokinase Sales Market Share by Application (2019-2030)
6.2 Global Urokinase Revenue Forecast by Application (2019-2030)
6.2.1 Global Urokinase Revenue by Application (2019-2024)
6.2.2 Global Urokinase Revenue Forecast by Application (2025-2030)
6.2.3 Global Urokinase Revenue Market Share by Application (2019-2030)
6.3 Urokinase Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Urokinase Market Size YoY Growth 2019-2030
7.2 North America Urokinase Market Facts & Figures by Country
7.2.1 North America Urokinase Sales by Country (2019-2030)
7.2.2 North America Urokinase Revenue by Country (2019-2030)
7.3 North America Urokinase Sales by Type (2019-2024)
7.4 North America Urokinase Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Urokinase Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Urokinase Market Facts & Figures by Region
8.2.1 Asia-Pacific Urokinase Sales by Region (2019-2030)
8.2.2 Asia-Pacific Urokinase Revenue by Region (2019-2030)
8.3 Asia-Pacific Urokinase Sales by Type (2019-2024)
8.4 Asia-Pacific Urokinase Sales by Application (2019-2024)
9 Europe
9.1 Europe Urokinase Market Size YoY Growth 2019-2030
9.2 Europe Urokinase Market Facts & Figures by Country
9.2.1 Europe Urokinase Sales by Country (2019-2030)
9.2.2 Europe Urokinase Revenue by Country (2019-2030)
9.3 Europe Urokinase Sales by Type (2019-2024)
9.4 Europe Urokinase Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Urokinase Market Size YoY Growth 2019-2030
10.2 Latin America Urokinase Market Facts & Figures by Country
10.2.1 Latin America Urokinase Sales by Country (2019-2030)
10.2.2 Latin America Urokinase Revenue by Country (2019-2030)
10.3 Latin America Urokinase Sales by Type (2019-2024)
10.4 Latin America Urokinase Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Urokinase Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Urokinase Market Facts & Figures by Country
11.2.1 Middle East and Africa Urokinase Sales by Country (2019-2030)
11.2.2 Middle East and Africa Urokinase Revenue by Country (2019-2030)
11.3 Middle East and Africa Urokinase Sales by Type (2019-2024)
11.4 Middle East and Africa Urokinase Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Urokinase Supply Chain Analysis
12.2 Urokinase Key Raw Materials and Upstream Suppliers
12.3 Urokinase Clients Analysis
12.4 Urokinase Sales Channel and Sales Model Analysis
12.4.1 Urokinase Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Urokinase Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Urokinase Distributors
13 Market Dynamics
13.1 Urokinase Industry Trends
13.2 Urokinase Market Drivers
13.3 Urokinase Market Challenges
13.4 Urokinase Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer